Knowledge

Lateral hypothalamus

Source 📝

792:
which have shown there is an association between changes in the Ox receptors and headaches (see below) (Rainero et al., 2004) and a recent multicentre case-control study revealed that chronic pain is more common in patients with narcolepsy with cataplexy than in the controls ... The orexin system has also been found to effect visceral functions, in addition to its roles in energy homeostasis and endocrine function, mentioned previously. ... orexin excites MCH neurons (van den Pol et al., 2004) and inhibits ventral medial hypothalamic (VMH) glucoreceptors to enhance feeding behaviours (Shiraishi et al., 2000). Moreover, a recent study demonstrated that the area postrema and nucleus of the tractus solitarius (NTS) are necessary for orexin-mediated hyperphagia ... However, i.v. injections of orexin-A have no effect on sympathetic activity (Matsumura et al., 2001), suggesting that the cardiac effects of orexin are mediated centrally. Consistently, microinjections of orexin-A into the rostral ventrolateral medulla (Huang et al., 2010) or rostral ventromedial medulla (Ciriello and de Oliveira, 2003) elicit cardiovascular excitatory responses through the activation of both OX1 and OX2 receptors (Huang et al., 2010).
1301:
well; the dopaminergic neurons originate in ventral tegmental area (VTA); and the histaminergic pathway originates from neurons in the tuberomammillary nucleus (TMN) of the posterior hypothalamus. As discussed in Chapter 6, these neurons project widely throughout the brain from restricted collections of cell bodies. Norepinephrine, serotonin, dopamine, and histamine have complex modulatory functions and, in general, promote wakefulness. The PT in the brain stem is also an important component of the ARAS. Activity of PT cholinergic neurons (REM-on cells) promotes REM sleep. During waking, REM-on cells are inhibited by a subset of ARAS norepinephrine and serotonin neurons called REM-off cells. ... Orexin neurons are located in the lateral hypothalamus. They are organized in a widely projecting manner, much like the monoamines (Chapter 6), and innervate all of the components of the ARAS. They excite the REM-off monoaminergic neurons during wakefulness and the PT cholinergic neurons during REM sleep. They are inhibited by the VLPO neurons during NREM sleep.
722:(TMN), serotonergic raphe nuclei, cholinergic laterodorsal and pedunculopontine nuclei (LDT and PPT), and the dopaminergic ventral tegmental area (VTA). ... Orexin neurons project to and activate monoaminergic and cholinergic neurons involved in the maintenance of a long "awake" period. Lack of orexin produces narcolepsy (Chapter 12). Orexin neurons are regulated by peripheral mediators that carry information about energy balance, including glucose, leptin, and ghrelin. They also receive inputs from limbic structures. Orexin neurons are, therefore, in a position not only to regulate sleep-wake cycles, but also to respond to significant environmental and metabolic signals. Accordingly, orexin plays a role in the regulation of energy homeostasis, reward, and perhaps more generally in emotion. 1061:
CB1 is shown to co-localize with the food intake inhibiting neuropeptide, corticotrophin-releasing hormone, in the paraventricular nucleus of the hypothalamus, and with the two orexigenic peptides, melanin-concentrating hormone in the lateral hypothalamus and with pre-pro-orexin in the ventromedial hypothalamus (Inui, 1999; Horvath, 2003). CB1 knockout (KO) mice showed higher levels of CRH mRNA, suggesting that hypothalamic EC receptors are involved in energy balance and may be able to mediate food intake (Cota et al., 2003). ... The ECS works through many anorexigenic and orexigenic pathways where ghrelin, leptin, adiponectin, endogenous opioids, and corticotropin-releasing hormones are involved (Viveros et al., 2008).
1458:
phosphorylation in the RVLM. We tested the novel hypothesis that brainstem orexin-A/OX1R signaling plays a pivotal role in the central CB1R-mediated pressor response. Our multiple labeling immunofluorescence findings revealed co-localization of CB1R, OX1R and the peptide orexin-A within the C1 area of the rostral ventrolateral medulla (RVLM). Activation of central CB1R following intracisternal (i.c.) WIN55,212–2 (15μg/rat) in conscious rats caused significant increases in BP and orexin-A level in RVLM neuronal tissue. Additional studies established a causal role for orexin-A in the central CB1R-mediated pressor response
795:
vagal pancreatic efferent nerve activities (Wu et al., 2004), stimulating pancreatic exocrine secretion (Miyasaka et al., 2002). Administration of orexin-A, i.a., increases duodenal secretion in normal fed but not in fasted animals, by an effect that is independent of cholinergic pathways (Flemstrom et al., 2003; Bengtsson et al., 2007). In addition, orexin-A can modify gastrointestinal motility, including gastric emptying, gastric interdigestive motility (Naslund et al., 2002; Ehrstrom et al., 2005a,b2005b; Bulbul et al., 2010), and enteric peristalsis (Satoh et al., 2006), as well as colonic motility ...
941:
for the first time that orexin-A specifically acts centrally in the brain to enhance antinociceptive response to colonic distension. We would furthermore suggest that endogenous orexin-A indeed mediates the antinociceptive effect of morphine on visceral sensation through the orexin 1 receptors. All these evidence might indicate that brain orexin plays a role in the pathophysiology of functional gastrointestinal disorders such as irritable bowel syndrome because visceral hypersensitivity of the gut is considered to play a vital role in the diseases.
870:
CB1-HcrtR1 heteromer compared with the HcrtR1-HcrtR1 homomer was reported (Ward et al., 2011b). These data provide unambiguous identification of CB1-HcrtR1 heteromerization, which has a substantial functional impact. ... The existence of a cross-talk between the hypocretinergic and endocannabinoid systems is strongly supported by their partially overlapping anatomical distribution and common role in several physiological and pathological processes. However, little is known about the mechanisms underlying this interaction.
1490:
peak and trough incidence among those born in March and September, respectively (suggesting an environmental influence during the fetal or perinatal period), and the loss of orexin neurons raise the interesting possibility that narcolepsy may be caused by an autoimmune mediated destruction of these neurons in analogy with the autoimmune destruction of insulin-secreting β-islet cells in type I diabetes. A search for small-molecule agonists at orexin receptors is underway and could lead to a treatment for narcolepsy.
331: 266: 28: 1200:
heterodi-/oligomeric complexes. However, it is unclear whether this affects their signaling. As orexin receptors efficiently signal via endocannabinoid production to CB1 receptors, dimerization could be an effective way of forming signal complexes with optimal cannabinoid concentrations available for cannabinoid receptors.
1300:
The RAS is a complex structure consisting of several different circuits including the four monoaminergic pathways ... The norepinephrine pathway originates from the locus ceruleus (LC) and related brainstem nuclei; the serotonergic neurons originate from the raphe nuclei within the brainstem as
1060:
CB1 is present in neurons of the enteric nervous system and in sensory terminals of vagal and spinal neurons in the gastrointestinal tract (Massa et al., 2005). Activation of CB1 is shown to modulate nutrient processing, such as gastric secretion, gastric emptying, and intestinal motility. ...
940:
With regard to gastrointestinal functions, orexin-A acts centrally to regulate gastrointestinal functions such as gastric and pancreatic secretion, and gastrointestinal motility. ... Little is, however, known about a role of central orexin in visceral sensation. ... These results suggest
1489:
Most cases of narcolepsy in humans are not linked to mutations in the genes encoding orexin peptides or receptors, but are associated with significantly reduced, often undetectable, levels of orexin in cerebrospinal fluid and brain tissues. Together, the linkage of narcolepsy with HLA alleles, its
1000:
Orexins promote both arousal and feeding (Sweet et al., 1999). ... Orexin-A also influences body temperature. In fact, an ICV administration of orexin-A induces an increase in firing rate of the sympathetic nerves to BAT, accompanied with a rise in BAT and colonic temperatures (Monda et al.,
791:
Orexin neurons are excitatory, express the vesicular glutamate transporter VGLUT2 (Rosin et al., 2003), and also produce dynorphin ... The analgesic properties of orexin peptides have been well-established ... The involvement of orexin in pain is also supported by clinical observations,
721:
Orexinergic projections in the CNS. Orexin neurons with cell bodies in the lateral hypothalamic area (LHA) and posterior hypothalamus (PH) project throughout the brain (excluding the cerebellum) with dense projections to the noradrenergic locus ceruleus (LC), histaminergic tuberomamillary nucleus
794:
However, orexin-A signalling in the nucleus ambiguus (NA) (de Oliveira and Ciriello, 2003) and subfornical organ (Smith et al., 2007) has been shown to produce bradycardia responses ... Moreover, activation of OX1 receptors in the dorsal motor nucleus of the vagus results in facilitation of
1355:
In this review we focus on the role of orexin in cardio-respiratory functions and its potential link to hypertension. ... the central chemoreflex may be a causal link to the increased SNA and ABP in SHRs. Modulation of the orexin system could be a potential target in treating some forms of
1157:
OX1–CB1 dimerization was suggested to strongly potentiate orexin receptor signaling, but a likely explanation for the signal potentiation is, instead, offered by the ability of OX1 receptor signaling to produce 2-arachidonoyl glycerol, a CB1 receptor ligand, and a subsequent co-signaling of the
1457:
Orexin receptor 1 (OX1R) signaling is implicated in cannabinoid receptor 1 (CB1R) modulation of feeding. Further, our studies established the dependence of the central CB1R-mediated pressor response on neuronal nitric oxide synthase (nNOS) and extracellular signal-regulated kinase1/2 (ERK1/2)
869:
Direct CB1-HcrtR1 interaction was first proposed in 2003 (Hilairet et al., 2003). Indeed, a 100-fold increase in the potency of hypocretin-1 to activate the ERK signaling was observed when CB1 and HcrtR1 were co-expressed ... In this study, a higher potency of hypocretin-1 to regulate
538:
Through the diverse outputs of the orexin system, the orexin neurons in the lateral hypothalamus mediate an array of functions. Two of the most commonly noted functions of orexin peptides in the lateral hypothalamus are the promotion of feeding behavior and arousal (i.e., wakefulness). More
1199:
Orexin receptor subtypes readily formed homo- and hetero(di)mers, as suggested by significant BRET signals. CB1 receptors formed homodimers, and they also heterodimerized with both orexin receptors. ... In conclusion, orexin receptors have a significant propensity to make homo- and
797:
The presence of orexin-A and its receptors has been shown in human kidneys and urine ... These findings are supported by results from physiological studies, which demonstrated that orexin-A is involved in the pelvic-urethral reflex (Peng et al., 2008) and the micturition
1173:
Jäntti MH, Mandrika I, Kukkonen JP (March 2014). "Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors".
405:. The histaminergic, dopaminergic, serotonergic, noradrenergic, and cholinergic nuclei which the lateral hypothalamic orexin neurons project onto constitute the primary components of the 602:
and the orexin system mediate many of the same cognitive and physical effects, and a significant overlap in their function and localization has been noted in a 2013 medical review; the
157:, digestive functions, and blood pressure, among many others. Clinically significant disorders that involve dysfunctions of the orexinergic projection system include 97: 1214:"Organization of connections between the amygdala, medial prefrontal cortex, and lateral hypothalamus: a single and double retrograde tracing study in rats" 1270: 1419:"A pivotal role for enhanced brainstem Orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats" 705:
Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 6: Widely Projecting Systems: Monoamines, Acetylcholine, and Orexin". In Sydor A, Brown RY (eds.).
636:
is associated with a marked reduction in the number of orexinergic projection neurons from the lateral hypothalamus and very low orexin peptides in
85: 149:; this system of neurons mediates an array of cognitive and physical processes, such as promoting feeding behavior and arousal, reducing 1849: 958:
Messina G, Dalia C, Tafuri D, Monda V, Palmieri F, Dato A, Russo A, De Blasio S, Messina A, De Luca V, Chieffi S, Monda M (2014).
278: 2004: 1158:
receptors (Haj-Dahmane and Shen, 2005; Turunen et al., 2012; Jäntti et al., 2013). However, this does not preclude dimerization.
1541: 1730: 406: 664: 382: 166: 1725: 2014: 2009: 1980: 1482: 1293: 1089: 714: 644: 548: 366: 2080: 1897: 104: 1786: 309: 682: 2134: 1713: 402: 1975: 1904: 1709: 622: 497: 465: 214: 92: 903: 510:
on orexinergic projection neurons in the lateral hypothalamus and many output structures, where the CB1 and
245:
on orexinergic projection neurons in the lateral hypothalamus and many output structures, where the CB1 and
1650: 461: 342: 283: 1686: 361:
The orexinergic projections from the lateral hypothalamus innervate the entirety of the remainder of the
1752: 1655: 1534: 1473:
Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 12: Sleep and Arousal". In Sydor A, Brown RY (eds.).
1284:
Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 12: Sleep and Arousal". In Sydor A, Brown RY (eds.).
592: 481: 429: 1747: 1705: 660: 544: 489: 485: 477: 413: 170: 162: 209:
are the primary signaling neurochemicals in orexin neurons; pathway-specific neurochemicals include
60: 2232: 2191: 2117: 1966: 1696: 398: 370: 321: 174: 43: 1514: 1509: 1504: 885: 880: 875: 2112: 2052: 1700: 1675: 1519: 1370:"Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review" 2222: 2129: 1892: 1826: 1821: 1803: 599: 564: 527: 523: 503: 386: 238: 80: 897: 895: 893: 617:
signaling. Unique functional interactions have been noted as well, such as an OX1-induced CB1
2217: 1877: 1836: 1798: 1781: 1720: 1691: 1527: 1079: 441: 2075: 1860: 1791: 1621: 1593: 890: 539:
generally, the orexinergic neural projections of the lateral hypothalamus are involved in
341: with: The list of outputs included here is not a comprehensive list. You can help by 8: 2227: 2181: 2154: 1999: 1867: 1841: 1505:
Figure 1: Schematic of brain CB1 expression and orexinergic neurons expressing OX1 or OX2
876:
Figure 1: Schematic of brain CB1 expression and orexinergic neurons expressing OX1 or OX2
637: 556: 519: 2158: 2021: 1882: 1767: 1762: 1757: 1443: 1418: 1394: 1369: 1341: 1314: 1238: 1213: 1143: 1116: 1046: 1019: 986: 959: 931: 855: 828: 777: 752: 572: 829:"Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far" 1872: 1831: 1588: 1478: 1448: 1399: 1346: 1289: 1243: 1190: 1148: 1085: 1051: 991: 923: 904:"Antinociceptive action against colonic distension by brain orexin in conscious rats" 860: 782: 710: 610: 511: 453: 385:. In addition to the histaminergic nucleus, the orexin system also projects onto the 304: 246: 1262: 1020:"The endocannabinoid system: directing eating behavior and macronutrient metabolism" 2107: 1990: 1855: 1616: 1438: 1434: 1430: 1389: 1381: 1336: 1326: 1233: 1225: 1182: 1138: 1128: 1041: 1031: 981: 971: 935: 919: 915: 850: 840: 772: 764: 618: 540: 473: 469: 449: 433: 181: 154: 640:. This has been identified as the mechanism responsible for narcoleptic symptoms. 2195: 2146: 2042: 1947: 1942: 1933: 1887: 1735: 902:
Okumura T, Nozu T, Kumei S, Takakusaki K, Miyagishi S, Ohhira M (February 2015).
652: 445: 378: 188: 73: 48: 507: 242: 1937: 1660: 1611: 1385: 1186: 390: 146: 1229: 1168: 1166: 2211: 2047: 1331: 1133: 1036: 976: 845: 606: 568: 560: 515: 493: 437: 417: 250: 2186: 2094: 1918: 1813: 1742: 1578: 1551: 1452: 1403: 1350: 1277: 1247: 1194: 1163: 1152: 1055: 995: 927: 864: 786: 656: 425: 394: 362: 199: 142: 753:"The hypocretins/orexins: integrators of multiple physiological functions" 110: 2173: 2030: 1957: 1670: 1603: 1563: 1555: 1510:
Figure 2: Synaptic signaling mechanisms in cannabinoid and orexin systems
881:
Figure 2: Synaptic signaling mechanisms in cannabinoid and orexin systems
614: 588: 552: 150: 138: 1410: 1110: 1108: 822: 820: 818: 816: 814: 812: 810: 808: 806: 330: 265: 686: 648: 633: 457: 218: 192: 158: 55: 1477:(2nd ed.). New York: McGraw-Hill Medical. pp. 294–296, 303. 768: 595:) via a group of structures in the brain stem, among other functions. 518:. There is substantial anatomical and functional overlap and systemic 1105: 803: 514:(OX1) receptors physically and functionally join to form the CB1–OX1 374: 226: 184: 27: 2026: 1635: 1583: 1475:
Molecular Neuropharmacology: A Foundation for Clinical Neuroscience
1286:
Molecular Neuropharmacology: A Foundation for Clinical Neuroscience
707:
Molecular Neuropharmacology: A Foundation for Clinical Neuroscience
584: 580: 576: 421: 206: 202: 67: 1549: 2062: 1288:(2nd ed.). New York, USA: McGraw-Hill Medical. p. 295. 1115:
Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP (2014).
234: 222: 230: 196: 1515:
Figure 3: Schematic of brain pathways involved in food intake
886:
Figure 3: Schematic of brain pathways involved in food intake
1114: 960:"Orexin-A controls sympathetic activity and eating behavior" 709:(2nd ed.). New York: McGraw-Hill Medical. p. 179. 1081:
The orexin/hypocretin system physiology and pathophysiology
210: 1073: 1071: 1069: 901: 1117:"OX1 and OX2 orexin/hypocretin receptor pharmacogenetics" 826: 746: 744: 742: 740: 738: 736: 734: 732: 730: 643:
Evidence suggest that OX1 neurons that synapse onto the
609:
produces a 100-fold amplification of the potency of the
1468: 1466: 1315:"Orexin, cardio-respiratory function, and hypertension" 1066: 957: 229:
peptides, and the appetite-regulating peptide hormones
1172: 727: 1306: 953: 951: 949: 827:
Flores A, Maldonado R, Berrendero F (December 2013).
587:) through other hypothalamic outputs, and regulating 1463: 1271:
University of Texas Health Science Center at Houston
1472: 1416: 1367: 1283: 1175:
Biochemical and Biophysical Research Communications
1013: 1011: 1009: 704: 946: 603: 32:Lateral hypothalamus is 'LT', at right, in yellow. 1211: 2209: 1006: 1535: 1084:. Totowa, N.J: Humana Press. pp. 25–35. 1417:Ibrahim BM, Abdel-Rahman AA (October 2015). 750: 700: 698: 696: 694: 547:and gastrointestinal function by way of the 1542: 1528: 1368:Ibrahim BM, Abdel-Rahman AA (March 2014). 1017: 26: 1981:Posterior (sympathetic/heat conservation) 1442: 1393: 1340: 1330: 1237: 1142: 1132: 1077: 1045: 1035: 985: 975: 854: 844: 776: 691: 555:through several output structures (e.g., 1361: 1312: 628: 591:(e.g., respiration, blood pressure, and 393:noradrenergic nucleus, the serotonergic 1212:Reppucci CJ, Petrovich GD (July 2016). 751:Li J, Hu Z, de Lecea L (January 2014). 2210: 1523: 1267:Homeostasis and Higher Brain Function 665:functional gastrointestinal disorders 567:projections and other outputs in the 407:ascending reticular activating system 167:functional gastrointestinal disorders 1976:Anterior (parasympathetic/heat loss) 575:and neuroendocrine functions (e.g., 383:paraventricular hypothalamic nucleus 325: 260: 145:that widely projects throughout the 13: 1260: 412:Other output regions include: the 14: 2244: 2015:Parvocellular neurosecretory cell 2010:Magnocellular neurosecretory cell 1498: 1078:Sakurai N (2006). Seiji T (ed.). 645:dorsal nucleus of the vagus nerve 549:dorsal nucleus of the vagus nerve 365:, with robust projections to the 249:(OX1) receptors form the CB1–OX1 1898:Anterior trigeminothalamic tract 563:property of stimuli through the 329: 264: 105:Anatomical terms of neuroanatomy 1254: 1205: 757:British Journal of Pharmacology 310:Central nucleus of the amygdala 2135:Dorsal longitudinal fasciculus 1435:10.1016/j.brainres.2015.06.011 1218:Brain Structure & Function 920:10.1016/j.brainres.2014.12.021 676: 403:laterodorsal tegmental nucleus 1: 670: 623:rostral ventrolateral medulla 526:and orexin system within the 498:dorsal nucleus of vagus nerve 466:rostral ventrolateral medulla 460:substructures, including the 215:melanin-concentrating hormone 1651:Stria medullaris of thalamus 1374:Journal of Advanced Research 462:rostral ventromedial medulla 7: 2053:Suprachiasmatic (melatonin) 533: 155:regulating body temperature 10: 2249: 1656:Thalamic reticular nucleus 1386:10.1016/j.jare.2013.03.008 1187:10.1016/j.bbrc.2014.02.026 1018:Watkins BA, Kim J (2014). 482:pontine micturition center 430:periaqueductal gray matter 319: 315: 2172: 2145: 2093: 2061: 1989: 1965: 1956: 1926: 1917: 1812: 1669: 1643: 1634: 1602: 1571: 1562: 1319:Frontiers in Neuroscience 1263:"Limbic System: Amygdala" 1230:10.1007/s00429-015-1081-0 1121:Frontiers in Neuroscience 833:Frontiers in Neuroscience 661:visceral hypersensitivity 545:gastrointestinal motility 490:pontine respiratory group 486:ventral respiratory group 478:spinal trigeminal nucleus 414:ventromedial hypothalamus 377:projection nucleus), the 256: 237:, among others. Notably, 177:), and eating disorders. 171:visceral hypersensitivity 131:lateral hypothalamic area 103: 91: 79: 66: 54: 42: 37: 25: 20: 2192:Nuclei campi perizonalis 2118:Retinohypothalamic tract 1332:10.3389/fnins.2014.00022 1134:10.3389/fnins.2014.00057 1037:10.3389/fpsyg.2014.01506 977:10.3389/fpsyg.2014.00997 846:10.3389/fnins.2013.00256 559:matter), modulating the 399:pedunculopontine nucleus 371:tuberomammillary nucleus 322:Neurotransmitter systems 175:irritable bowel syndrome 137:), contains the primary 2113:Medial forebrain bundle 2043:Arcuate (dopamine/GHRH) 1313:Li A, Nattie E (2014). 1269:. Neuroscience Online. 1024:Frontiers in Psychology 964:Frontiers in Psychology 651:may play a role in the 422:central medial amygdala 2130:Mammillothalamic tract 1893:Subthalamic fasciculus 1827:Pallidothalamic tracts 1822:Mammillothalamic tract 1804:Interthalamic adhesion 600:endocannabinoid system 565:ventral tegmental area 528:central nervous system 524:endocannabinoid system 504:Cannabinoid receptor 1 387:ventral tegmental area 367:posterior hypothalamus 239:cannabinoid receptor 1 2157:is diencephalon, but 1878:Dentatothalamic tract 1837:Lenticular fasciculus 1799:Midline nuclear group 1265:. In Byrne JH (ed.). 629:Clinical significance 442:substantia innominata 416:, medial and lateral 1861:Trigeminal lemniscus 1622:Subcommissural organ 1594:Habenular commissure 607:receptor heterodimer 551:, reducing pain and 516:receptor heterodimer 251:receptor heterodimer 123:lateral hypothalamus 21:Lateral hypothalamus 2182:Subthalamic nucleus 2000:posterior pituitary 1868:Spinothalamic tract 1842:Thalamic fasciculus 638:cerebrospinal fluid 557:periaqueductal gray 141:nucleus within the 129:), also called the 1883:Acoustic radiation 884: • 879: • 874: • 589:visceral functions 573:energy homeostasis 397:, and cholinergic 389:dopamine nucleus, 282:. You can help by 163:motility disorders 2205: 2204: 2168: 2167: 2089: 2088: 1913: 1912: 1905:Medullary laminae 1873:Lateral lemniscus 1832:Ansa lenticularis 1630: 1629: 1589:Habenular trigone 769:10.1111/bph.12415 647:and parts of the 611:orexin receptor 1 512:orexin receptor 1 454:prefrontal cortex 359: 358: 305:prefrontal cortex 300: 299: 247:orexin receptor 1 119: 118: 114: 2240: 2108:Stria terminalis 1963: 1962: 1924: 1923: 1856:Medial lemniscus 1641: 1640: 1617:Habenular nuclei 1569: 1568: 1544: 1537: 1530: 1521: 1520: 1493: 1492: 1470: 1461: 1460: 1446: 1414: 1408: 1407: 1397: 1365: 1359: 1358: 1344: 1334: 1310: 1304: 1303: 1281: 1275: 1274: 1258: 1252: 1251: 1241: 1209: 1203: 1202: 1170: 1161: 1160: 1146: 1136: 1112: 1103: 1102: 1100: 1098: 1075: 1064: 1063: 1049: 1039: 1015: 1004: 1003: 989: 979: 955: 944: 943: 899: 888: 872: 858: 848: 824: 801: 800: 780: 748: 725: 724: 702: 689: 680: 619:pressor response 605: 541:thermoregulation 474:solitary nucleus 470:nucleus ambiguus 450:stria terminalis 434:lateral habenula 354: 351: 333: 326: 295: 292: 281: 268: 261: 189:endocannabinoids 182:neurotransmitter 111:edit on Wikidata 108: 30: 18: 17: 2248: 2247: 2243: 2242: 2241: 2239: 2238: 2237: 2233:Sleep disorders 2208: 2207: 2206: 2201: 2196:Fields of Forel 2164: 2141: 2085: 2057: 2048:Preoptic (GnRH) 2005:Paraventricular 1985: 1952: 1943:Mammillary body 1934:Median eminence 1909: 1888:Optic radiation 1808: 1736:Pulvinar nuclei 1674: 1665: 1626: 1598: 1558: 1550:Anatomy of the 1548: 1501: 1496: 1485: 1471: 1464: 1415: 1411: 1366: 1362: 1311: 1307: 1296: 1282: 1278: 1259: 1255: 1210: 1206: 1171: 1164: 1113: 1106: 1096: 1094: 1092: 1076: 1067: 1016: 1007: 956: 947: 900: 891: 883: 878: 873: 825: 804: 796: 793: 749: 728: 717: 703: 692: 681: 677: 673: 653:pathophysiology 631: 536: 446:nucleus basalis 379:arcuate nucleus 355: 349: 346: 339:needs expansion 324: 318: 296: 290: 287: 277: 274:needs expansion 259: 151:pain perception 115: 33: 12: 11: 5: 2246: 2236: 2235: 2230: 2225: 2220: 2203: 2202: 2200: 2199: 2189: 2184: 2178: 2176: 2170: 2169: 2166: 2165: 2163: 2162: 2151: 2149: 2143: 2142: 2140: 2139: 2138: 2137: 2132: 2122: 2121: 2120: 2115: 2110: 2099: 2097: 2091: 2090: 2087: 2086: 2084: 2083: 2078: 2073: 2067: 2065: 2059: 2058: 2056: 2055: 2050: 2045: 2036: 2035: 2034: 2033: 2019: 2018: 2017: 2012: 1995: 1993: 1987: 1986: 1984: 1983: 1978: 1972: 1970: 1960: 1954: 1953: 1951: 1950: 1945: 1940: 1938:Tuber cinereum 1930: 1928: 1921: 1915: 1914: 1911: 1910: 1908: 1907: 1901: 1900: 1895: 1890: 1885: 1880: 1875: 1870: 1865: 1864: 1863: 1858: 1846: 1845: 1844: 1839: 1834: 1824: 1818: 1816: 1810: 1809: 1807: 1806: 1801: 1796: 1795: 1794: 1784: 1775: 1774: 1773: 1772: 1771: 1770: 1765: 1760: 1750: 1740: 1739: 1738: 1733: 1728: 1718: 1717: 1716: 1703: 1689: 1680: 1678: 1667: 1666: 1664: 1663: 1661:Taenia thalami 1658: 1653: 1647: 1645: 1638: 1632: 1631: 1628: 1627: 1625: 1624: 1619: 1614: 1612:Pretectal area 1608: 1606: 1600: 1599: 1597: 1596: 1591: 1586: 1581: 1575: 1573: 1566: 1560: 1559: 1547: 1546: 1539: 1532: 1524: 1518: 1517: 1512: 1507: 1500: 1499:External links 1497: 1495: 1494: 1483: 1462: 1423:Brain Research 1409: 1360: 1305: 1294: 1276: 1253: 1224:(6): 2937–62. 1204: 1162: 1104: 1090: 1065: 1005: 945: 908:Brain Research 889: 802: 726: 715: 690: 674: 672: 669: 630: 627: 535: 532: 444:(contains the 391:locus ceruleus 357: 356: 336: 334: 317: 314: 313: 312: 307: 298: 297: 271: 269: 258: 255: 147:nervous system 117: 116: 107: 101: 100: 95: 89: 88: 83: 77: 76: 71: 64: 63: 58: 52: 51: 46: 40: 39: 35: 34: 31: 23: 22: 9: 6: 4: 3: 2: 2245: 2234: 2231: 2229: 2226: 2224: 2223:Limbic system 2221: 2219: 2216: 2215: 2213: 2197: 2193: 2190: 2188: 2185: 2183: 2180: 2179: 2177: 2175: 2171: 2160: 2156: 2153: 2152: 2150: 2148: 2144: 2136: 2133: 2131: 2128: 2127: 2126: 2123: 2119: 2116: 2114: 2111: 2109: 2106: 2105: 2104: 2101: 2100: 2098: 2096: 2092: 2082: 2079: 2077: 2074: 2072: 2069: 2068: 2066: 2064: 2060: 2054: 2051: 2049: 2046: 2044: 2041: 2038: 2037: 2032: 2028: 2025: 2024: 2023: 2020: 2016: 2013: 2011: 2008: 2007: 2006: 2003: 2001: 1997: 1996: 1994: 1992: 1988: 1982: 1979: 1977: 1974: 1973: 1971: 1968: 1964: 1961: 1959: 1955: 1949: 1946: 1944: 1941: 1939: 1935: 1932: 1931: 1929: 1925: 1922: 1920: 1916: 1906: 1903: 1902: 1899: 1896: 1894: 1891: 1889: 1886: 1884: 1881: 1879: 1876: 1874: 1871: 1869: 1866: 1862: 1859: 1857: 1854: 1853: 1852: 1851: 1847: 1843: 1840: 1838: 1835: 1833: 1830: 1829: 1828: 1825: 1823: 1820: 1819: 1817: 1815: 1811: 1805: 1802: 1800: 1797: 1793: 1790: 1789: 1788: 1785: 1783: 1780: 1777: 1776: 1769: 1766: 1764: 1761: 1759: 1756: 1755: 1754: 1751: 1749: 1746: 1745: 1744: 1741: 1737: 1734: 1732: 1729: 1727: 1724: 1723: 1722: 1719: 1715: 1711: 1707: 1704: 1702: 1698: 1695: 1694: 1693: 1690: 1688: 1685: 1682: 1681: 1679: 1677: 1672: 1668: 1662: 1659: 1657: 1654: 1652: 1649: 1648: 1646: 1642: 1639: 1637: 1633: 1623: 1620: 1618: 1615: 1613: 1610: 1609: 1607: 1605: 1601: 1595: 1592: 1590: 1587: 1585: 1582: 1580: 1577: 1576: 1574: 1570: 1567: 1565: 1561: 1557: 1553: 1545: 1540: 1538: 1533: 1531: 1526: 1525: 1522: 1516: 1513: 1511: 1508: 1506: 1503: 1502: 1491: 1486: 1484:9780071481274 1480: 1476: 1469: 1467: 1459: 1454: 1450: 1445: 1440: 1436: 1432: 1428: 1424: 1420: 1413: 1405: 1401: 1396: 1391: 1387: 1383: 1380:(2): 137–45. 1379: 1375: 1371: 1364: 1357: 1356:hypertension. 1352: 1348: 1343: 1338: 1333: 1328: 1324: 1320: 1316: 1309: 1302: 1297: 1295:9780071481274 1291: 1287: 1280: 1272: 1268: 1264: 1257: 1249: 1245: 1240: 1235: 1231: 1227: 1223: 1219: 1215: 1208: 1201: 1196: 1192: 1188: 1184: 1181:(2): 486–90. 1180: 1176: 1169: 1167: 1159: 1154: 1150: 1145: 1140: 1135: 1130: 1126: 1122: 1118: 1111: 1109: 1093: 1091:9781592599509 1087: 1083: 1082: 1074: 1072: 1070: 1062: 1057: 1053: 1048: 1043: 1038: 1033: 1029: 1025: 1021: 1014: 1012: 1010: 1002: 997: 993: 988: 983: 978: 973: 969: 965: 961: 954: 952: 950: 942: 937: 933: 929: 925: 921: 917: 913: 909: 905: 898: 896: 894: 887: 882: 877: 871: 866: 862: 857: 852: 847: 842: 838: 834: 830: 823: 821: 819: 817: 815: 813: 811: 809: 807: 799: 788: 784: 779: 774: 770: 766: 763:(2): 332–50. 762: 758: 754: 747: 745: 743: 741: 739: 737: 735: 733: 731: 723: 718: 716:9780071481274 712: 708: 701: 699: 697: 695: 688: 684: 679: 675: 668: 666: 662: 658: 654: 650: 646: 641: 639: 635: 626: 624: 620: 616: 612: 608: 601: 596: 594: 590: 586: 582: 578: 574: 571:, regulating 570: 569:reward system 566: 562: 558: 554: 550: 546: 543:, regulating 542: 531: 529: 525: 521: 517: 513: 509: 505: 501: 499: 495: 494:area postrema 491: 487: 483: 479: 475: 471: 467: 463: 459: 455: 451: 447: 443: 439: 438:diagonal band 435: 431: 427: 423: 419: 418:septal nuclei 415: 410: 408: 404: 400: 396: 392: 388: 384: 380: 376: 372: 368: 364: 353: 344: 340: 337:This section 335: 332: 328: 327: 323: 311: 308: 306: 302: 301: 294: 285: 280: 275: 272:This section 270: 267: 263: 262: 254: 252: 248: 244: 240: 236: 232: 228: 224: 220: 216: 212: 208: 204: 201: 200:neuropeptides 198: 194: 190: 186: 183: 178: 176: 172: 168: 164: 160: 156: 152: 148: 144: 140: 136: 132: 128: 124: 112: 106: 102: 99: 96: 94: 90: 87: 84: 82: 78: 75: 72: 69: 65: 62: 59: 57: 53: 50: 47: 45: 41: 36: 29: 24: 19: 16: 2218:Hypothalamus 2187:Zona incerta 2161:is glandular 2124: 2102: 2095:White matter 2076:Ventromedial 2070: 2039: 1998: 1948:Infundibulum 1919:Hypothalamus 1848: 1814:White matter 1792:Centromedian 1787:Intralaminar 1778: 1743:Metathalamus 1683: 1579:Pineal gland 1552:diencephalon 1488: 1474: 1456: 1426: 1422: 1412: 1377: 1373: 1363: 1354: 1322: 1318: 1308: 1299: 1285: 1279: 1266: 1256: 1221: 1217: 1207: 1198: 1178: 1174: 1156: 1124: 1120: 1095:. Retrieved 1080: 1059: 1027: 1023: 999: 967: 963: 939: 911: 907: 868: 836: 832: 790: 760: 756: 720: 706: 678: 657:chronic pain 642: 632: 597: 537: 522:between the 502: 426:zona incerta 411: 395:raphe nuclei 363:hypothalamus 360: 347: 343:adding to it 338: 288: 284:adding to it 273: 179: 143:hypothalamus 134: 130: 126: 122: 120: 86:A14.1.08.929 74:birnlex_4037 15: 2174:Subthalamus 2081:Dorsomedial 2031:vasopressin 1958:Grey matter 1671:Grey matter 1604:Grey matter 1564:Epithalamus 1556:human brain 615:ERK pathway 553:nociception 508:colocalized 276: with: 243:colocalized 139:orexinergic 38:Identifiers 2228:Narcolepsy 2212:Categories 2022:Supraoptic 1261:Wright A. 687:NeuroNames 671:References 649:brain stem 634:Narcolepsy 613:-mediated 520:cross-talk 458:brain stem 456:, various 381:, and the 320:See also: 219:nociceptin 195:) and the 193:anandamide 169:involving 159:narcolepsy 56:NeuroNames 2155:Posterior 2147:Pituitary 1991:Endocrine 1967:Autonomic 1429:: 51–63. 593:urination 561:rewarding 506:(CB1) is 375:histamine 350:July 2015 291:July 2015 279:this list 241:(CB1) is 227:dynorphin 185:glutamate 2159:anterior 2125:efferent 2103:afferent 2027:oxytocin 1779:midline: 1636:Thalamus 1584:Habenula 1453:26096126 1404:25685481 1351:24574958 1248:26169110 1195:24530395 1153:24834023 1056:25610411 1030:: 1506. 996:25250003 928:25527398 914:: 12–7. 865:24391536 787:24102345 683:hier-409 585:HPT axis 581:HPG axis 577:HPA axis 534:Function 207:orexin-B 203:orexin-A 187:and the 68:NeuroLex 2071:Lateral 2063:Emotion 1927:Surface 1721:Lateral 1692:Ventral 1684:paired: 1644:Surface 1572:Surface 1554:of the 1444:4562882 1395:4294710 1342:3921571 1239:4713378 1144:4018553 1097:19 July 1047:4285050 987:4157463 970:: 997. 936:7239191 856:3868890 839:: 256. 778:3904255 621:in the 604:CB1–OX1 316:Outputs 303:Medial 235:ghrelin 223:glucose 191:(e.g., 173:(e.g., 49:D007026 2040:other: 1768:K cell 1763:M cell 1758:P cell 1676:nuclei 1481:  1451:  1441:  1402:  1392:  1349:  1339:  1325:: 22. 1292:  1246:  1236:  1193:  1151:  1141:  1127:: 57. 1088:  1054:  1044:  1001:2001). 994:  984:  934:  926:  863:  853:  798:reflex 785:  775:  713:  583:, and 496:, and 488:, and 257:Inputs 231:leptin 225:, the 197:orexin 153:, and 1969:zones 932:S2CID 373:(the 109:[ 98:62030 1850:PCML 1479:ISBN 1449:PMID 1427:1622 1400:PMID 1347:PMID 1290:ISBN 1244:PMID 1191:PMID 1149:PMID 1099:2015 1086:ISBN 1052:PMID 992:PMID 924:PMID 912:1598 861:PMID 783:PMID 711:ISBN 659:and 598:The 401:and 233:and 211:GABA 205:and 180:The 121:The 81:TA98 44:MeSH 1714:VPL 1710:VPM 1439:PMC 1431:doi 1390:PMC 1382:doi 1337:PMC 1327:doi 1234:PMC 1226:doi 1222:221 1183:doi 1179:445 1139:PMC 1129:doi 1042:PMC 1032:doi 982:PMC 972:doi 916:doi 851:PMC 841:doi 773:PMC 765:doi 761:171 685:at 663:in 655:of 492:), 448:), 345:. 286:. 165:or 135:LHA 93:FMA 61:426 2214:: 1782:MD 1753:LG 1748:MG 1731:LP 1726:LD 1706:VP 1701:VL 1697:VA 1687:AN 1487:. 1465:^ 1455:. 1447:. 1437:. 1425:. 1421:. 1398:. 1388:. 1376:. 1372:. 1353:. 1345:. 1335:. 1321:. 1317:. 1298:. 1242:. 1232:. 1220:. 1216:. 1197:. 1189:. 1177:. 1165:^ 1155:. 1147:. 1137:. 1123:. 1119:. 1107:^ 1068:^ 1058:. 1050:. 1040:. 1026:. 1022:. 1008:^ 998:. 990:. 980:. 966:. 962:. 948:^ 938:. 930:. 922:. 910:. 906:. 892:^ 867:. 859:. 849:. 835:. 831:. 805:^ 789:. 781:. 771:. 759:. 755:. 729:^ 719:. 693:^ 667:. 625:. 579:, 530:. 500:. 484:, 480:, 476:, 472:, 468:, 464:, 452:, 440:, 436:, 432:, 428:, 424:, 420:, 409:. 369:, 253:. 221:, 217:, 213:, 161:, 127:LH 70:ID 2198:) 2194:( 2029:/ 2002:: 1936:/ 1712:/ 1708:/ 1699:/ 1673:/ 1543:e 1536:t 1529:v 1433:: 1406:. 1384:: 1378:5 1329:: 1323:8 1273:. 1250:. 1228:: 1185:: 1131:: 1125:8 1101:. 1034:: 1028:5 974:: 968:5 918:: 843:: 837:7 767:: 352:) 348:( 293:) 289:( 133:( 125:( 113:]

Index


MeSH
D007026
NeuroNames
426
NeuroLex
birnlex_4037
TA98
A14.1.08.929
FMA
62030
Anatomical terms of neuroanatomy
edit on Wikidata
orexinergic
hypothalamus
nervous system
pain perception
regulating body temperature
narcolepsy
motility disorders
functional gastrointestinal disorders
visceral hypersensitivity
irritable bowel syndrome
neurotransmitter
glutamate
endocannabinoids
anandamide
orexin
neuropeptides
orexin-A

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.